Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.77NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.26.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.10.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAY.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CY.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBTNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.33NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BM.1.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBMNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.34NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CB.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BR.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CL.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EF.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BR.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.2.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CP.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.4.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.132 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.1.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KF.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CS.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.83NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BJ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDGNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KD.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCSNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.7.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.15.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.40NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CR.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KB.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CJ.1.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XANNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.4.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DV.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used